Abstract Background: Fragile X syndrome (FXS) is associated with dysregulated endocannabinoid signaling and may therefore respond to cannabidiol therapy. Design:…
Abstract Background: Medical cannabinoids differ in their pharmacology and may have different treatment effects. We aimed to conduct a pharmacology-based…
Abstract Background: The Compassionate Access Scheme (CAS) being delivered through the Queensland Children’s Hospital is designed to allow access to…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s12859-021-04526-5. Article type: Research Article Keywords: Tissue heterogeneity, Cell…
Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that currently has no cure. The aged population is growing globally,…
Abstract Background: Despite repeated calls by medical associations to gather evidence on the harms and benefits of cannabis, there are…
Abstract Simple Summary: Pancreatic ductal adenocarcinoma is a devastating disease that is very hard to treat. Here, we advance and…
Abstract This review aims to present completed clinical trial data surrounding the medicinal benefits and potential side effects of the…
Abstract Agitation is a prevalent and difficult-to-treat symptom in patients with moderate-to-severe Alzheimer’s disease (AD). Though there are nonpharmacological and…
Abstract Background: Chronic pain affects a significant proportion of the population and presents a major challenge to clinicians and pain…